Canlyniadau Chwilio - Se‐Hoon Lee

Mireinio'r Canlyniadau
  1. 1
    Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics

    Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics gan Seo‐Yeon Park, Hei Sung Kim, Se‐Hoon Lee, Sungjoo Kim

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Clinicopathologic characteristics of <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> alterations in 6,595 lung cancers

    Clinicopathologic characteristics of <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> alterations in 6,595 lung cancers gan Boram Lee, Taebum Lee, Se‐Hoon Lee, Yoon‐La Choi, Joungho Han

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics

    Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics gan Yu Ri Woo, Se‐Hoon Lee, Sang Hyun Cho, Jeong Deuk Lee, Hei Sung Kim

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute

    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute gan Younak Choi, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dong‐Wan Kim, Dae Seog Heo

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

    Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib gan Youjin Kim, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer

    Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer gan Song Ee Park, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Analysis of the BRAFV600E Mutation in Central Nervous System Tumors

    Analysis of the BRAFV600E Mutation in Central Nervous System Tumors gan Jae Kyung Myung, Hwa Jin Cho, Chul‐Kee Park, Seung-Ki Kim, Se‐Hoon Lee, Sung‐Hye Park

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer

    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer gan Ahnah Song, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Bhumsuk Keam, Se‐Hoon Lee, Dae Seog Heo

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer

    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer gan Eunyoung Lee, Bhumsuk Keam, Dong‐Wan Kim, Tae Min Kim, Se‐Hoon Lee, Doo Hyun Chung, Dae Seog Heo

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis

    Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis gan Seonggyu Byeon, Jun Soo Ham, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma gan Hana Kim, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung‐Ju Ahn

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor

    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor gan Sehhoon Park, Seunggyun Ha, Se‐Hoon Lee, Jin Chul Paeng, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence gan Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Thyroid Cancer

    Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Thyroid Cancer gan Youngkyung Jeon, Sehhoon Park, Se‐Hoon Lee, Tae Hyuk Kim, Sun Wook Kim, Myung‐Ju Ahn, Hyun Ae Jung, Jae Hoon Chung

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Aggressiveness of Cancer-Care near the End-of-Life in Korea

    Aggressiveness of Cancer-Care near the End-of-Life in Korea gan Bhumsuk Keam, Djin‐Ye Oh, Se‐Hoon Lee, Dong‐Wook Kim, Mee‐Ran Kim, S. Im, Tae‐Yop Kim, Yung‐Jue Bang, D. S. Heo

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

    Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer gan Bo Mi Ku, Yeon Hee Bae, Kyoung Young Lee, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC

    DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC gan Sehhoon Park, Hayoon Lee, Boram Lee, Se‐Hoon Lee, Jong‐Mu Sun, Woong‐Yang Park, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer

    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer gan Ji Eun Shin, Hyun Ae Jung, Sehhoon Park, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Myung‐Ju Ahn, Byoung Yong Shim

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer

    Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer gan Soyeon Kim, Tae Min Kim, Dong Wan Kim, Heounjeong Go, Bhumsuk Keam, Se‐Hoon Lee, Ja-Lok Ku, Doo Hyun Chung, Dae Seog Heo

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm

    Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm gan Heounjeong Go, Dong‐Wan Kim, Donghyun Kim, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dae Seog Heo, Yung‐Jue Bang, Doo Hyun Chung

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: